Generation of brain and spinal cord neurons, cardiac myocytes, renal nephrons and hepatocytes using reg peptides, peptidomimetics, small molecules and stimulatory antibodies to reg receptor
US2019328839A1
Treatment of Type 1 Diabetes and Other Conditions Using the Gut Microbiome
US2019142901A1
Compositions and methods for treating or preventing type 1 diabetes using a biologic response modifier in combination with one or more islet or beta cell regeneration or replacement therapies
US2017081375A1
Generation of brain and spinal cord neurons, cardiac myocytes, renal nephrons and hepatocytes using reg peptides, peptidomimetics, small molecules and stimulatory antibodies to reg receptor
US2016039876A1
Insulin independence among patients with diabetes utilizing an optimized hamster reg3 gamma peptide
EP2941250A1
Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
AU2013323462A1
Generation of new pancreatic beta cells
AU2013323476A1
Insulin independence among patients with diabetes utilizing a PPI in combination with an immune tolerance agent
US8808689B1
Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
US2014235552A1
Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
US2014234405A1
Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
